Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...

Why scale matters when the disease is slow but relentless Dry age-related macular degeneration progresses in quiet increments ...

As many as 15 million people in the United States have some form of age-related macular degeneration, a leading cause of vision loss among people 50 and older. Nine out of 10 of them have the dry form ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the second of a three-part series on dry ...

Support local journalism. A digital subscription is incredibly affordable and makes you the most informed person around. Click here and subscribe today Many frightening thoughts may go through your ...

WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...

Today, in the New England Journal of Medicin e, researchers announced that they restored some vision to elderly patients with ...

Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...